BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Lilly reports full Q4 2024 financial results and provides 2025 guidance

  February 6, 2025

   · 

  22 min read
• Press Releases

  Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025

  February 6, 2025

   · 

  2 min read
• Press Releases

  STERIS Announces Financial Results for Fiscal 2025 Third Quarter

  February 6, 2025

   · 

  14 min read
• Press Releases

  Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology

  February 6, 2025

   · 

  2 min read
• Press Releases

  Immunovant Reports Financial Results for the Quarter Ended December 31, 2024

  February 6, 2025

   · 

  11 min read
• Press Releases

  Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

  February 6, 2025

   · 

  6 min read
• Press Releases

  Broken String Biosciences Launches Catalyst Program to Shorten Gene Editing Therapy Development by Months

  February 6, 2025

   · 

  5 min read
• Press Releases

  Kenvue Reports Full Year and Fourth Quarter 2024 Results

  February 6, 2025

   · 

  20 min read
• Press Releases

  Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024

  February 6, 2025

   · 

  19 min read
• Press Releases

  Mustang Bio Announces Pricing of $8 Million Public Offering

  February 6, 2025

   · 

  5 min read